ストックスクリーナーアプリを入手
11.03
3.08%
-0.35
プレマーケット:
10.30
-0.73
-6.62%
前日終値:
$11.38
開ける：
$11.28
24時間の取引高:
4,679
Relative Volume:
0.18
時価総額：
$53.35M
収益：
$2.61M
当期純損益:
$1.69M
株価収益率:
36.73
EPS:
0.3003
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+10.30%
1か月 パフォーマンス:
+18.73%
6か月 パフォーマンス:
+54.69%
1年 パフォーマンス:
+27.66%
1日の値動き範囲:
$10.26
$11.28
1週間の範囲:
$9.5309
$11.38
52週間の値動き範囲:
$6.55
$11.38
Daxor Corporation Stock (DXR) Company Profile
名前
Daxor Corporation
セクター
電話
212-330-8500
住所
Empire State Building, Suite 7120 350 Fifth Avenue, New York, NY
DXR を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
DXR
Daxor Corporation
|
11.03 | 56.47M | 2.61M | 1.69M | 0 | 0.3003 |
|
ISRG
Intuitive Surgical Inc
|
482.35 | 171.42B | 9.15B | 2.63B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
195.96 | 55.88B | 21.39B | 1.61B | 2.55B | 5.56 |
|
ALC
Alcon Inc
|
86.48 | 42.55B | 9.93B | 1.12B | 1.43B | 2.26 |
|
RMD
Resmed Inc
|
288.28 | 41.48B | 5.15B | 1.40B | 1.65B | 9.51 |
|
WST
West Pharmaceutical Services Inc
|
246.22 | 17.25B | 2.90B | 467.20M | 306.90M | 6.37 |
Daxor Corporation Stock (DXR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2019-05-16 | 開始されました | Ascendiant Capital Markets | Buy |
Daxor Corporation (DXR) 最新ニュース
FDA clearances: Imris, Daxor Corp., Tandem Diabetes Care - Modern Healthcare
How Daxor Corporation stock performs during market volatilityJuly 2025 Catalysts & Weekly Chart Analysis and Guides - Newser
Is Daxor Corporation forming a bottoming baseJuly 2025 Closing Moves & Weekly Setup with ROI Potential - Newser
Applying chart zones and confluence areas to Daxor Corporation2025 Support & Resistance & Short-Term High Return Ideas - Newser
How high can Daxor Corporation stock price go in 2025Weekly Investment Recap & Step-by-Step Swing Trade Plans - Newser
Key resistance and support levels for Daxor CorporationJuly 2025 PostEarnings & Reliable Price Breakout Alerts - Newser
Will Daxor Corporation continue its uptrendFree AI Driven Stock Trend Forecast - Newser
Is Daxor Corporation a candidate for recovery playFree AI Driven Stock Trend Forecast - Newser
Can machine learning forecast Shimmick Corporation recoverySafe Momentum Strategy With Trend Analysis - Newser
Using economic indicators to assess Daxor Corporation potentialWeekly Gain Forecast with Momentum Indicators - Newser
Daxor Corporation Announces Replay of Nasdaq Closing Bell Ceremony Now Available - GlobeNewswire
Daxor BVA Gets FDA Clearance, Celebrates Nasdaq Listing Milestone - AInvest
Revolutionary Hand-Held Blood Volume Analyzer Gets FDA Green Light: Daxor's Game-Changing Medical Innovation - Stock Titan
Financial Survey: DaVita (NYSE:DVA) vs. Daxor (NASDAQ:DXR) - Defense World
Will Daxor Corporation stock recover after recent dropHistorical Volatility and Pattern Breakdown Analysis - Newser
Daxor Corporation shares fall 8.83% after-hours despite FDA clearance for new Blood Volume Analyzer. - AInvest
Is a relief rally coming for Tamboran Resources Corporation holdersLong-Term Stock Growth Forecast Insights - Newser
Published on: 2025-08-12 05:36:50 - Newser
Real time social sentiment graph for Amphenol CorporationIntraday Signal Forecast for Fast Traders - Newser
What’s the recovery path for long term holders of Daxor CorporationRisk-Managed Strategy Based on Price Analysis - Newser
Can volume confirm reversal in Daxor CorporationFree Stock Selection With High Accuracy - Newser
Why Daxor Corporation stock attracts strong analyst attentionPrice Movement and Market Sentiment Analysis - Newser
Daxor Corporation Stock Chart Analysis: Bullish or Bearish Pattern FormingFree Low Capital High Return Stock Plans - Newser
Chart based analysis of Daxor Corporation trendsYearly Trend Summary and Opportunity Breakdown - Newser
What makes Daxor Corporation stock price move sharplySmart Money Strategy for Growth Stocks - Newser
Daxor Corporation Rings the Closing Bell - Nasdaq
Applying Wyckoff theory to Daxor Corporation stockCapital Safe Picks with Consistent Gains - Newser
Identifying reversal signals in Daxor CorporationSwing Trade Picks with High Potential - Newser
Tick level data insight on Daxor Corporation volatilityLong-Term Growth Trend Summary With Confidence - Newser
Daxor Corporation shares rise 4.40% intraday after FDA clearance for new Blood Volume Analyzer. - AInvest
Daxor (NASDAQ: DXR) Stock Rises After FDA Clears Breakthrough Blood Volume Analyzer for Clinical Care | DXR Stock Price - paginasiete.bo
Daxor Gains FDA Clearance for Blood Volume Analyzer - TipRanks
Daxor receives FDA clearance for next-gen blood volume analyzer By Investing.com - Investing.com Nigeria
Daxor receives FDA clearance for next-gen blood volume analyzer - Investing.com
Daxor stock soars after FDA clearance for new blood volume analyzer By Investing.com - Investing.com South Africa
Daxor stock soars after FDA clearance for new blood volume analyzer - Investing.com Nigeria
Daxor Corporation Announces FDA Clearance for Revolutionary Blood Volume Analyzer to Improve Patient Outcomes - Quiver Quantitative
Daxor Corporation Receives FDA Clearance for New Rapid, Lightweight, Blood Volume Analysis System - GlobeNewswire
Breakthrough: FDA Approves Game-Changing Blood Volume Analyzer That Cuts Mortality by 86% - Stock Titan
Has Daxor Corporation found a price floorPre-Market Stock Movement Summary and Review - Newser
Daxor Corporation (DXR) 財務データ
収益
当期純利益
現金流量
EPS
3.74%
大文字化:
|
ボリューム (24 時間):